Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities:    
Net loss $ (14,400) $ (14,167)
Adjustments required to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 358 356
Impairment of investment in a subsidiary 396
Interest on short term loans and revolving credit line 547
Sale of subsidiary shares to non-controlling interests 635
Liability for minimum royalties 114 24
Stock-based compensation 2,221 399
Modification of terms relating to straight loan transaction 88
Share in losses of affiliated company 492
Change in fair value, amortization of discounts and accrued interest on convertible bridge loans 9,779 13,648
Amortization of discounts and accrued interest on straight loans 653
Change in fair value of derivative warrants liability and fair value of warrants expired (294)
Change in fair value of liability related to conversion feature of convertible bridge loans (3,614) (4,307)
Decrease (increase) in trade receivables 1,129 (1,168)
Increase in inventories 79 (1,348)
Decrease (increase) in other current assets (468) 712
Increase (decrease) in accounts payable 1,262 (481)
Decrease in deferred revenues (857)
Increase (decrease) in other current liabilities (513) 260
Operating lease liability (48)
Net cash used in operating activities (2,523) (5,990)
Cash flows from investing activities:    
Purchase of property and equipment (3) (770)
Cash used in purchased of subsidiary (1,176)
Investment in other companies (635)
Net cash used in investing activities (3) (2,581)
Cash flows from financing activities:    
Proceeds from straight loans and revolving credit line 3,974 1,850
Repayment of Receivables financing facility   (1,249)
Repayment of straight loans (1,620) (1,058)
Repayment of convertible bridge loans   (2,166)
Proceeds from issuance of units consisting of convertible bridge loans, stock warrants and shares, net   10,312
Proceeds from issuance of ordinary shares through equity line   255
Net cash provided by financing activities 2,354 7,944
Change in cash, cash equivalents (172) (627)
Cash, cash equivalents at beginning of period 189 935
Cash, cash equivalents at end of period 17 308
Supplemental disclosure of non-cash activities:    
Issuance of warrants as part of bridge loan transactions 3,430
Partial conversion of convertible bridge loans and liability related to conversion feature of convertible bridge loans into ordinary shares 3,483 8,646
Issuance of ordinary shares for call option to acquire potential acquiree 1,804  
Issuance of stock warrants as part of convertible bridge loan received 870
Issuance of ordinary shares upon modification of terms relating to convertible straight loan transaction 792
Shares issued in settlement of a financial liability 200
Issuance of shares upon acquisition of an asset $ 396
Working capital (excluding cash and cash equivalents)   (18)
Fixed assets   183
Long term assets   3
Net assets acquired   168
Goodwill acquired   7,761
Intangible assets acquired   1,500
Second cash installment payable   (1,250)
Consideration in convertible promissory note   (4,989)
Consideration in Shares   (1,699)
Deferred tax liability   (315)
Net cash used in purchase of subsidiary consolidated for the first time   $ 1,176